Omadacycline Shows Promise as Safe, Effective C Diff Antibiotic Compared to Vancomycin

Participants given omadacycline had high fecal concentrations with a distinct microbiome profile compared to those in the vancomycin group, with study results calling attention to the importance of antibiotics’ impact on the gut microbiome.

Related Keywords

United States ,Kevin Garey ,Robertl Boblitt ,University Of Houston College Pharmacy ,Us Centers For Disease ,University Of Houston Kevin Garey ,University Of Houston ,Robertl Boblitt Endowed Professor ,Drug Discovery ,Houston College ,Disease Control ,Gut Microbiome Effects ,Oral Omadacycline Versus Vancomycin ,Healthy Volunteers ,Infectious Diseases ,C Diff ,Clostridioides Difficile ,Wvancomycin ,Omadacycline ,Antibiotic ,Recurrence ,Microbiome ,Microbiota ,Fecal Pharmacokinetics ,